Skip to main content
. 2015 Jun 4;26(11):2821–2829. doi: 10.1681/ASN.2014121233

Table 2.

Melamine concentrations and renal function indicators in different specimens in melamine tableware manufacturing workers by worksites and their comparison group

Variables Exposed Workers (n=44) Nonexposed Workers Controls (N=105) P valuea (Overall) P valueb (Manufacturers versus Controls)
Manufacturers (N=16) Grinders (N=8) Packers (N=10) Administrators (N=10)
Mean±SD (median, IQR)
Exposure markers
 Urine
  Melamine (ng/ml) 917.6±516.4 188.0±107.4 292.6±363.6 109.8±214.7 8.1±9.1 <0.001 <0.001
   (943.0, 438.0–1251.8) (206.3, 64.7–291.6) (252.6, 42.4–390.3) (18.2, 12.6–101.3) (4.3, 1.6–11.2)c
  Melamine (μg/mmol Cr) 84.4±47.4 18.4±9.7 24.2±23.0 4.6±6.8 0.7±0.9 <0.001 <0.001
(80.5, 51.3–112.9) (16.2, 12.3–29.5) (15.9, 3.9–46.7) (1.9, 1.0–5.2) (0.3, 0.1–1.0)c
 Serum
  Melamine (ng/ml), N (%)
   Non-detectabled 0 5 (62.5) 7 (70.0) 7 (70.0) <0.001
   Detectable 16 (100.0) 3 (37.5) 3 (30.0) 3 (30.0)
7.2±4.6 2.4±0.3 3.6±2.2 1.7±0.4
(6.7, 4.0–9.6) (2.4, 2.0–) (2.4, 2.2–) (1.6, 1.5–)
Nephrolithiasis markers
 Urine
 Microalbumin (mg/mmol Cr) 14.8±49.2 1.0±0.6 0.8±0.5 1.5±2.7 1.9±6.8 0.486 0.248
(0.8, 0.4–2.5) (0.5, 0.5–1.7) (0.7, 0.4–1.5) (0.4, 0.3–1.5) (0.6, 0.4–0.9)
 NAG (IU/mmol Cr) 1.8±3.5 0.9±0.8 0.6±0.4 0.6±0.3 0.4±0.2 0.002 0.002
(0.9, 0.4–1.4) (0.8, 0.3–0.9) (0.5, 0.3–0.9) (0.6, 0.3–0.9) (0.4, 0.3–0.5)
β2-microglobulin, N (%)
  Nondetectablee 10 (62.5) 6 (75.0) 9 (90.0) 9 (90.0) 101 (96.2) 0.006 0.007
  Detectable 4 (25.0) 1 (12.5) 0 0 4 (3.8)
  Missing 2 (12.0) 1 (12.5) 1 (10.0) 1 (10.0) 0
Laboratory data
 eGFR 83.4±14.0 81.0±12.1 82.7±8.2 80.0±10.1 77.8±9.7 0.383 0.246
(79.6, 72.7–91.5) (82.0, 70.9–88.1) (86.0, 75.1–88.6) (79.9, 73.3–88.5) (77.4, 71.4–84.7)
 eCCR 80.8±12.0 78.9±14.0 82.0±15.4 98.1±35.4 78.4±13.2 0.518 0.375
(79.7, 75.5–90.6) (79.7, 68.0–86.7) (79.3, 69.6–96.8) (84.0, 73.6–117.9) (77.6, 68.6–88.0)
 eGFR<60 mL/min/1.73 m2, N (%) 0 0 0 0 4 (3.8)
Urine, mg/dl
  Creatinine 142.9±64.1 123.1±60.2 140.7±52.0 185.2±92.2 143.7±78.3 0.706 0.843
(139.4, 81.0–202.7) (112.9, 95.7–145.3) (139.5, 87.2–181.7) (150.9, 116.1–276.8) (124.9, 83.0–202.9)
Serum, mg/dl
  BUN 15.1±4.6 14.0±3.1 13.2±3.2 14.1±3.6 13.1±2.7f 0.541 0.141
   (15.4, 11.5–18.1) (14.0, 11.7–16.9) (12.6, 10.9–15.6) (13.6, 11.8–17.8) (13.0, 10.7–14.8)
  Creatinine 1.0±0.2 0.9±0.2 0.9±0.1 1.0±0.1 1.1±0.1f <0.001 0.116
   (1.0, 0.8–1.1) (0.9, 0.8–1.0) (0.9, 0.8–1.0) (1.0, 0.9–1.0) (1.1, 1.0–1.1)
  Uric acid 5.7±1.6 5.7±2.6 5.1±1.4 6.8±1.2 6.0±1.3f 0.061 0.162
(5.6, 4.4–6.5) (5.4, 3.7–7.6) (5.1, 4.0–6.1) (6.6, 5.6–8.0) (5.9, 5.1–7.0)

IQR, interquartile range; Cr, creatinine; eGFR, estimated glomerular filtration rate calculated by the Modification of Diet in Renal Disease calculator-extended version (adjusted by age, gender, serum creatinine, and race), unit as ml/min/1.73 m2; eCCr, estimated creatinine clearance rate calculated by the Modification of the Cockcroft–Gault Calculator (adjusted by age, gender, serum creatinine, and weight), unit as ml/min.

a

Kruskal–Wallis test or chi-squared test.

b

Wilcoxon rank-sum test or Fisher’s exact test.

c

n=42.

d

MDL of melamine in serum: 1.33 ng/ml.

e

MDL for β2-microglobulin: 0.206 mg/l.

f

Missing data, n=2.